Stay updated on ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedThe site-wide footer revision label changes from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA notice about NIH’s website transition and terminology appears above the error page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check32 days agoChange DetectedThe site's footer revision identifier advances from v3.7.0 to v3.7.1; the study record view still displays a 403 Forbidden page.SummaryDifference0.2%

- Check46 days agoChange DetectedA large block of text detailing data sharing, IPD availability, and related study documents is removed from the study record. The deletions also remove guidance on where to access IPD plans, documents, and participation-related information, reducing on-page guidance and transparency.SummaryDifference18%

- Check53 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0, indicating a small update to the record. This is a metadata change and does not alter the study content or substantive information presented on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a small system update rather than changes to study details or page content.SummaryDifference0.0%

Stay in the know with updates to ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.